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ABSTRACT
It is often said that challenges can be viewed as opportunities in disguise.
This is certainly true as we, the Colleges and Schools of Marshall University,
Marshall Health, Cabell Huntington Hospital and Mountain Health Network,
independently and collectively navigate the uncharted waters associated with
COVID-19.
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It is often said that challenges can be viewed as
opportunities in disguise. This is certainly true as
we, the Colleges and Schools of Marshall University,
Marshall Health, Cabell Huntington Hospital and
Mountain Health Network, independently and
collectively navigate the uncharted waters associated
with COVID-19. The daily commitment and passion
of our clinicians, scientists and educators is creatively
focused on maintaining the health and wellness
of our patients, students and colleagues. Yet, these
times have also unveiled future challenges that we
in West Virginia, the Tri-State area, and beyond will
need to resolve in order to minimize disruption to our
daily lives. Our future will be based in large part upon
how well we can effectively work as interprofessional
teams of clinicians, educators and scientists. Several
challenges in providing timely and appropriate
healthcare have been revealed with COVID-19. These
and other currently unforeseen challenges will be
the ones we will need to tackle in order to maintain
successful patient outcomes in our urban and rural
communities.
It is clear we will need to continue to provide health
care professionals that will serve our urban and rural
communities in Appalachia and beyond. The health
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professional schools of Marshall University remain
committed to this endeavor. We work to attract
and support students in their education as future
physicians, pharmacists, physician assistants, nurses,
physical therapists, medical laboratory technicians,
social workers, public health workers, dieticians,
audiologists and speech-language pathologists.
While we cannot clearly determine the totality of
the economic impact of COVID-19 on our students’
abilities to pursue or complete their studies at this
time, our current clinicians, faculty members, and
friends are working to minimize disruptions. We
have learned in the current time the importance of
enhancing and providing stable internet connections
for all our students across West Virginia and beyond.
Additionally, this is a time for the Marshall University
health science programs to collectively work with
our communities to encourage even more students
to consider professions in healthcare particularly
as nurses, pharmacists and other health care first
responders. An advantage of Marshall University is
the number of undergraduate and graduate health
professions programs that students can pursue and
the great potential for interprofessional education
and practice in our care of patients.
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A second area of concern that has been exacerbated
and most likely will continue in the future is key
drug shortages in our hospitals and community
pharmacies. Drug shortages have always been a part
of contemporary healthcare settings in hospitals
and community pharmacies. The reason for drug
shortages can include off-shore manufacturing
and quality problems resulting in shortages in
active pharmaceutical ingredients, delays, and
discontinuations. For example, COVID-19 has
resulted in disruptions of at least 156 critical drugs
manufactured in China, Italy, India or other countries
as reported by the Center for Infectious Disease
Research and Policy (CIDRAP) at the University of
Minnesota.1 The Food and Drug Administration
(FDA) is responsible for working closely with the
manufacturers to limit or reduce the impact of these
shortages. However, with COVID-19 we are seeing
additional disruptions in the supply chain of essential
drugs and testing reagents that may continue well
beyond the current situation.2 Hospital pharmacists
and pharmacies are well acquainted with the
challenges of drug shortages particularly intravenous
fluids and injectable drugs. Hospital pharmacies often
have dedicated staff (pharmacists and associated
staff ) to serve as a resource for the clinicians while
managing and minimizing these shortages in patient
care activities in their institution or healthcare system.
These drug shortages are listed in two real-time
on-line references; 1) the American Society of HealthSystem Pharmacists Drug Shortages3 and 2) the Food
and Drug Administration Drug Shortages2.
However, in the ambulatory care and community
pharmacy settings, a system to minimize the
effect of drug shortages on patient care is not as
well organized in the current health care system.
The challenge arises when the clinician writes the
prescription and the patient goes to the community
pharmacy only to find out that this specific drug is
not available due to the shortage. The next step is the
pharmacist taking time to call community pharmacies
in the area to see if they have the drug and/or to call
the physician’s office to discuss the shortage situation
and possible therapeutic options. This comes at a
cost, however, as time is lost for the pharmacist,
physician and staff members of the clinic and
pharmacy that would otherwise be used for direct
patient care activities. Imagine a situation where one’s
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home is in a rural setting, one can certainly envision
how a drug shortage of specific orally administrated
drugs could impact on the treatment of chronic
disease conditions, particularly if there is a limited
number of pharmacies in their community.
With an eye towards solving this challenge now
and in the future, this is an excellent time for the
Marshall University School of Pharmacy and the
Joan C. Edwards School of Medicine to collaborate
with community pharmacies and pharmacists in
developing strategies to identify and minimize
these drug shortages. Physicians and pharmacists in
ambulatory care clinics working with pharmacists in
their community pharmacies are excellent partners
who can provide insight into developing strategies
that can be used to solve this challenge. This
solution could involve the development of an online
searchable resource that would provide current upto-date drug shortages of relevant drugs used in the
clinic setting combined with the availability of these
specific drugs in community pharmacies. This would
involve two key components, 1) pharmacists and
physicians working together to identify therapeutic
options for specific drug shortages that could be
used by their colleagues if a drug is not available
and 2) a tool that could be used by clinic physicians
and nurses as well as community pharmacists to
provide the names of community pharmacies where
the patients could find the prescribed drug. As a
starting point, the School of Pharmacy and the
School of Medicine are working together to develop
the on-line resource for therapeutic options for
drug shortages that could be used by clinicians and
nurses in the clinics and by community pharmacists.
We are also reaching out to community pharmacies
to establish efficient and real-time approaches to
collect information on the availability of drugs that
may be in short supply in our area and eventually
throughout the state.
A third area of concern that we may see as a result of
COVID-19 is the continued closure of pharmacies in
rural and urban communities resulting in these areas
being considered a pharmacy desert. A pharmacy
desert is defined as any area where patients have
poor access to prescription medications. This
lack of access can be a result of long distances to
get to the pharmacy because of closures, limited
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transportation, insurance status, and lower incomes.4
It has been suggested that nearly 100 million
Americans lack adequate access to pharmacies.5
West Virginia is no exception in that we have seen a
continued decline in the number of pharmacies in
both our urban and rural communities combined
with long distances between our communities.
One reason that continues to lead to the loss of
community pharmacies around the country is the
declining reimbursements that a pharmacy receives
when filling the prescription order; this is having a
significant impact on the business’ financial stability.

and sites in West Virginia. We, pharmacists and
physicians, collectively need to work with our local
governments, the West Virginia Legislature and the
Governor’s Office to ensure the availability of patient
care provided at local clinics and pharmacies. While
COVID-19 has and continues to be a challenge to
providing successful patient outcomes, this can
also be the time for physicians and pharmacists to
think creatively about new strategies for enhanced
collaboration focused always on optimizing patient
care in West Virginia and beyond.

The impact of COVID-19 on future pharmacy
closures is not known at this stage. Yet there is
concern that many of these struggling pharmacies
have become frontline sources of patient care
and information in their communities. What
will happen in the future if there are shortages
in available prescribed drugs as well as in new
drugs and vaccinations? Similar declines have also
been observed in access to patient care in rural
and underserved settings. We continue to see
few physicians choosing to work in these areas
combined with the closure of community hospitals
and health care facilities in West Virginia and the
nation.6-8 Like on community pharmacies, the impact
of COVID-19 on rural patient care is also unknown
at this stage, but this will provide yet another strain
on already a fragile health care system in rural and
underserved areas. The decline of primary care and
pharmacy services combined with the impact of
COVID-19 in our rural and underserved communities
provides another leadership opportunity for
our Schools of Pharmacy and Medicine and for
individual physicians and pharmacists to work
together. Physician-pharmacist collaborative
management (PPCM) has been shown to improve
the management of patients with chronic diseases.9
This is particularly relevant to ambulatory care clinics
as recently approved West Virginia legislation allows
pharmacists to bill for services provided that are
within their scope of practice if these benefits would
be provided for such services performed by other
health care providers.10
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COVID-19 has certainly tested our educational
and health care systems. Yet, we should also
consider how this situation has provided us with
openings to now advance innovative practice tools
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